These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 16801562)

  • 1. Identification of novel antimicrobials using a live-animal infection model.
    Moy TI; Ball AR; Anklesaria Z; Casadei G; Lewis K; Ausubel FM
    Proc Natl Acad Sci U S A; 2006 Jul; 103(27):10414-10419. PubMed ID: 16801562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The worm turns for antimicrobial discovery.
    Bhavsar AP; Brown ED
    Nat Biotechnol; 2006 Sep; 24(9):1098-100. PubMed ID: 16964218
    [No Abstract]   [Full Text] [Related]  

  • 3. High-throughput screen for novel antimicrobials using a whole animal infection model.
    Moy TI; Conery AL; Larkins-Ford J; Wu G; Mazitschek R; Casadei G; Lewis K; Carpenter AE; Ausubel FM
    ACS Chem Biol; 2009 Jul; 4(7):527-33. PubMed ID: 19572548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Immune Modulators Enhance
    Hummell NA; Revtovich AV; Kirienko NV
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33408224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of potential anti-infectives against Staphylococcus aureus using a Caenorhabditis elegans infection model.
    Kong C; Yehye WA; Abd Rahman N; Tan MW; Nathan S
    BMC Complement Altern Med; 2014 Jan; 14():4. PubMed ID: 24393217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both live and dead Enterococci activate Caenorhabditis elegans host defense via immune and stress pathways.
    Yuen GJ; Ausubel FM
    Virulence; 2018 Dec; 9(1):683-699. PubMed ID: 29436902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-animal chemical screen identifies colistin as a new immunomodulator that targets conserved pathways.
    Cai Y; Cao X; Aballay A
    mBio; 2014 Aug; 5(4):. PubMed ID: 25118236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caenorhabditis elegans susceptibility to gut Enterococcus faecalis infection is associated with fat metabolism and epithelial junction integrity.
    Sim S; Hibberd ML
    BMC Microbiol; 2016 Jan; 16():6. PubMed ID: 26769134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An efficient and novel screening model for assessing the bioactivity of extracts against multidrug-resistant Pseudomonas aeruginosa using Caenorhabditis elegans.
    Zhou YM; Shao L; Li JA; Han LZ; Cai WJ; Zhu CB; Chen DJ
    Biosci Biotechnol Biochem; 2011; 75(9):1746-51. PubMed ID: 21897025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A liaR deletion restores susceptibility to daptomycin and antimicrobial peptides in multidrug-resistant Enterococcus faecalis.
    Reyes J; Panesso D; Tran TT; Mishra NN; Cruz MR; Munita JM; Singh KV; Yeaman MR; Murray BE; Shamoo Y; Garsin D; Bayer AS; Arias CA
    J Infect Dis; 2015 Apr; 211(8):1317-25. PubMed ID: 25362197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole animal automated platform for drug discovery against multi-drug resistant Staphylococcus aureus.
    Rajamuthiah R; Fuchs BB; Jayamani E; Kim Y; Larkins-Ford J; Conery A; Ausubel FM; Mylonakis E
    PLoS One; 2014; 9(2):e89189. PubMed ID: 24586584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple model host for identifying Gram-positive virulence factors.
    Garsin DA; Sifri CD; Mylonakis E; Qin X; Singh KV; Murray BE; Calderwood SB; Ausubel FM
    Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10892-7. PubMed ID: 11535834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An integrated microfluidic platform for evaluating in vivo antimicrobial activity of natural compounds using a whole-animal infection model.
    Yang J; Chen Z; Ching P; Shi Q; Li X
    Lab Chip; 2013 Sep; 13(17):3373-82. PubMed ID: 23824379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Realgar increases defenses against infection by Enterococcus faecalis in Caenorhabditis elegans.
    Ma W; Yue J; Liang S; Gao M; Wang X; Cui N; Li H; Zhi D
    J Ethnopharmacol; 2021 Mar; 268():113559. PubMed ID: 33159994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genomic virulence reference map of Enterococcus faecalis reveals an important contribution of phage03-like elements in nosocomial genetic lineages to pathogenicity in a Caenorhabditis elegans infection model.
    La Rosa SL; Snipen LG; Murray BE; Willems RJ; Gilmore MS; Diep DB; Nes IF; Brede DA
    Infect Immun; 2015 May; 83(5):2156-67. PubMed ID: 25776747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enterococcus faecalis mutations affecting virulence in the Caenorhabditis elegans model host.
    Maadani A; Fox KA; Mylonakis E; Garsin DA
    Infect Immun; 2007 May; 75(5):2634-7. PubMed ID: 17307944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Swietenia macrophylla extract promotes the ability of Caenorhabditis elegans to survive Pseudomonas aeruginosa infection.
    Dharmalingam K; Tan BK; Mahmud MZ; Sedek SA; Majid MI; Kuah MK; Sulaiman SF; Ooi KL; Khan NA; Muhammad TS; Tan MW; Shu-Chien AC
    J Ethnopharmacol; 2012 Jan; 139(2):657-63. PubMed ID: 22193176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The worm has turned--microbial virulence modeled in Caenorhabditis elegans.
    Sifri CD; Begun J; Ausubel FM
    Trends Microbiol; 2005 Mar; 13(3):119-27. PubMed ID: 15737730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Mechanism of Quorum-Sensing in Enterococcus faecalis: Its Role in Virulence and Therapeutic Approaches.
    Ali L; Goraya MU; Arafat Y; Ajmal M; Chen JL; Yu D
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28467378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial resistance profile of Enterococcus species isolated from intestinal tracts of hospitalized patients in Jimma, Ethiopia.
    Abamecha A; Wondafrash B; Abdissa A
    BMC Res Notes; 2015 Jun; 8():213. PubMed ID: 26036911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.